ipilimumab,nivolumab,durvalumab,paclitaxel,vinorelbine,carboplatin,cisplatin,gemcitabine,docetaxel,pemetrexed
bms,astrazeneca
['durva', 'cm816']
the % of patients not making it to surgery is a worry (although similar to cm816). we need to see this data by cstage and understand whether it was iiia/iiib w/ advanced disease or other reasons. what happens to these patients? can they be converted to crt/durva? #aacr23 
Thoracic surgeon expecting excellence. Cancer researcher. Patient advocate. #LungCancer #lcsm @lung_fund